How are CGMs the backbone of hybrid closed loop systems and how can they help your diabetes control?
Everything you need to know about extended wear time, new devices & recent integrations

Hybrid Closed Loop Systems
The five FDA-approved systems continue to advance with machine learning capabilities that adapt to individual patterns. These systems are approaching true “set it and forget it” functionality that requires minimal user input beyond normal daily activities.

Dual-Hormonal Systems
They represent the next frontier, using both insulin (“the gas pedal”) and glucagon (“the brakes”) to automate blood glucose management. Clinical trials show an impressive 80% Time-in-Range with virtually no input required from users, bringing us closer to a physiological cure.

Continuous Ketone Monitors (CKMs)
They are emerging rapidly, providing critical insights into normal ketone patterns in Type 1 diabetes and enabling early detection of Diabetic Ketoacidosis (DKA). This technology is especially important for people with diabetes using SGLT inhibitors, which may become more widely prescribed as CKM adoption increases. 

And most importantly! Learn how YOU can benefit from these updates in the near future!